3 months ago
MIR
AnalystsYuan ZhiYuan Zhi's Stock Forecasts
AnalystsYuan Zhi
Analyst Ranking
Top 10%
#468 out of 5081 analysts
Average Return
+39.2%
Win Rate
45%14 out of 31
Risk vs Reward
Poor
Good
Yuan Zhi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fusion Pharmaceuticals IncFUSN | +554.97% | $3.22 | $21.09 | 2023-10-03 - 2024-03-20 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +446.37% | $3.86 | $21.09 | 2023-03-30 - 2024-03-20 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +141.92% | $2.29 | $5.54 | 2022-12-01 - 2023-11-30 | Strong Buy |
Tango Therapeutics IncTNGX | +131.66% | $3.38 | $7.83 | 2024-11-11 - 2025-10-29 | Strong Buy |
Mirion Technologies IncMIR | +114.96% | $13.84 | $29.75 | 2025-04-16 - 2025-10-29 | Strong Buy |
Yuan Zhi Analyst Color
Get additional color on Yuan Zhi's coverage of popular stocks
4 months ago
CATX
2 years ago
CATX
2 years ago
AZTA
Yuan Zhi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirion Technologies IncMIR | 3 | Strong Buy | $22.00 | -26.05% | Reiterates | 3 months ago |
Oncology Institute IncTOI | 1 | Strong Buy | $6.00 | +27.66% | Initiates Coverage On | 3 months ago |
Perspective Therapeutics IncCATX | 3 | Strong Buy | $12.00 | +339.56% | Maintains | 4 months ago |
Radnet IncRDNT | 1 | Strong Buy | $69.00 | -12.48% | Initiates Coverage On | 5 months ago |
Hyperfine IncHYPR | 2 | Strong Buy | $1.00 | -13.79% | Maintains | 5 months ago |
Radiopharm Theranostics LtdRADX | 1 | Strong Buy | $15.00 | +199.40% | Initiates Coverage On | 8 months ago |
Tango Therapeutics IncTNGX | 2 | Strong Buy | $8.00 | +2.17% | Maintains | a year ago |
Agenus IncAGEN | 2 | Strong Buy | $18.00 | N/A | Maintains | a year ago |
Cryoport IncCYRX | 4 | Strong Buy | $15.00 | N/A | Upgrades | a year ago |
Cytosorbents CorpCTSO | 1 | Strong Buy | $3.00 | N/A | Reiterates | a year ago |
Fusion Pharmaceuticals IncFUSN | 4 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Azenta IncAZTA | 3 | Strong Buy | $79.00 | N/A | Maintains | 2 years ago |
Ambrx Biopharma IncAMAM | 2 | Hold | $28.00 | N/A | Downgrades | 2 years ago |
Actinium Pharmaceuticals IncATNM | 4 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Iveric Bio IncISEE | 3 | Hold | $19.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.